Sintaho Pharmaceutical Ltd was established in the year of 2016 and headquartered in Chongqing China, with a grand vison of being the most trusted partner to pharmaceutical companies worldwide. We have a clear focus on developing and manufacturing highly potent and cytotoxic Active Pharmaceutical Ingredients (APIs) and CDMO services.
*The following content is generated by AI and is for reference only.
<h3>Overview</h3>
<p>CAY-PNP refers to a specialized phosphonate intermediate in fine chemical synthesis. The core process involves enzymatic or catalytic hydrolysis of pyridine nucleotides. <strong>Molecular Formula</strong>: C10H14N5O7P2S; <strong>CAS No.</strong>: 68-95-1 (Common PNP reference). This compound serves as a critical reagent for kinetic assays.</p>
<h3>Application</h3>
<ul>
<li>Pharmaceutical R&D: Used in high-throughput screening for phosphatase inhibitors.</li>
<li>Diagnostics: Acts as a substrate in colorimetric enzyme-linked immunosorbent assays (ELISA).</li>
<li>Biochemistry: Essential for studying metabolic pathways involving pyrophosphate cleavage.</li>
</ul>
<h3>Precautions</h3>
<p>Requires storage at -20°C under inert atmosphere to prevent hydrolysis. Personnel must wear nitrile gloves and safety goggles due to potential irritant properties. Avoid inhalation of dust particles during handling.</p>